Early Detection of Mesothelioma


Related Videos (117)

Anil Vachani, MD, Director of Clinical Research for Penn Interventional Pulmonary Services, outlines the challenges inherent in the early detection of mesothelioma, a disease that may be asymptomatic for decades before the first symptoms appear. Dr. Vachani reviews the current diagnostic armamentarium, including the blood tests (serum mesothelin, plasma osteopontin, fibulin­3 and HMGB1) and screening tools (serum mesothelin), concluding with a discussion of mesothelioma studies in the Philadelphia region.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®